Skip to main content

Table 2 Showing comparison of menstrual characteristics of WWE on CBM and LTM monotherapy

From: Determinants of quality of life in Nigerian female patients with epilepsy on carbamazepine and levetiracetam monotherapy

Variables

CBM

LTM

Test

p-value

Menarche mean (SD)

11.5 (1.1)

11.9 (1.4)

− 16.00

0.094

Dysmenorrhea N(%)

12(24.0)

40(80.0)

31.41

0.000*

Menses pattern N(%)

17.13

0.000*

 Oligomenorrhea

13(26.0)

12(24.0)

 Hypermenorrhea

19(38.0)

3(6.0)

 Normal

18(36.0)

35(70.0)

Hirsutism N(%)

1(2.0)

10(20.0)

8.27

0.004*

Dyspareunia N(%)

6(12.0)

13(26.0)

57.27

0.000*

Intermenstrual bleeding N(%)

0(0.0)

9(18.0)

70.48

0.000*

Catamenial epilepsy N(%)

1(2.0)

5(10.0)

2.84

0.092

  1. CBM carbamazepine, LTM levetiracetam
  2. *Statistically significant